PReS-FINAL-2162: Development of a risk model to predict methotrexate intolerance in juvenile idiopathic arthritis

Detalles Bibliográficos
Autores principales: Van Dijkhuizen, P, Bulatovic-Calasan, M, Pluijm, S, De Rotte, M, Vastert, B, Kamphuis, S, De Jonge, R, Wulffraat, N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4044067/
http://dx.doi.org/10.1186/1546-0096-11-S2-P174
_version_ 1782319074648260608
author Van Dijkhuizen, P
Bulatovic-Calasan, M
Pluijm, S
De Rotte, M
Vastert, B
Kamphuis, S
De Jonge, R
Wulffraat, N
author_facet Van Dijkhuizen, P
Bulatovic-Calasan, M
Pluijm, S
De Rotte, M
Vastert, B
Kamphuis, S
De Jonge, R
Wulffraat, N
author_sort Van Dijkhuizen, P
collection PubMed
description
format Online
Article
Text
id pubmed-4044067
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40440672014-06-17 PReS-FINAL-2162: Development of a risk model to predict methotrexate intolerance in juvenile idiopathic arthritis Van Dijkhuizen, P Bulatovic-Calasan, M Pluijm, S De Rotte, M Vastert, B Kamphuis, S De Jonge, R Wulffraat, N Pediatr Rheumatol Online J Poster Presentation BioMed Central 2013-12-05 /pmc/articles/PMC4044067/ http://dx.doi.org/10.1186/1546-0096-11-S2-P174 Text en Copyright © 2013 Van Dijkhuizen et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Van Dijkhuizen, P
Bulatovic-Calasan, M
Pluijm, S
De Rotte, M
Vastert, B
Kamphuis, S
De Jonge, R
Wulffraat, N
PReS-FINAL-2162: Development of a risk model to predict methotrexate intolerance in juvenile idiopathic arthritis
title PReS-FINAL-2162: Development of a risk model to predict methotrexate intolerance in juvenile idiopathic arthritis
title_full PReS-FINAL-2162: Development of a risk model to predict methotrexate intolerance in juvenile idiopathic arthritis
title_fullStr PReS-FINAL-2162: Development of a risk model to predict methotrexate intolerance in juvenile idiopathic arthritis
title_full_unstemmed PReS-FINAL-2162: Development of a risk model to predict methotrexate intolerance in juvenile idiopathic arthritis
title_short PReS-FINAL-2162: Development of a risk model to predict methotrexate intolerance in juvenile idiopathic arthritis
title_sort pres-final-2162: development of a risk model to predict methotrexate intolerance in juvenile idiopathic arthritis
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4044067/
http://dx.doi.org/10.1186/1546-0096-11-S2-P174
work_keys_str_mv AT vandijkhuizenp presfinal2162developmentofariskmodeltopredictmethotrexateintoleranceinjuvenileidiopathicarthritis
AT bulatoviccalasanm presfinal2162developmentofariskmodeltopredictmethotrexateintoleranceinjuvenileidiopathicarthritis
AT pluijms presfinal2162developmentofariskmodeltopredictmethotrexateintoleranceinjuvenileidiopathicarthritis
AT derottem presfinal2162developmentofariskmodeltopredictmethotrexateintoleranceinjuvenileidiopathicarthritis
AT vastertb presfinal2162developmentofariskmodeltopredictmethotrexateintoleranceinjuvenileidiopathicarthritis
AT kamphuiss presfinal2162developmentofariskmodeltopredictmethotrexateintoleranceinjuvenileidiopathicarthritis
AT dejonger presfinal2162developmentofariskmodeltopredictmethotrexateintoleranceinjuvenileidiopathicarthritis
AT wulffraatn presfinal2162developmentofariskmodeltopredictmethotrexateintoleranceinjuvenileidiopathicarthritis

Ejemplares similares